scholarly journals Tumor suppressor p53 regulates insulin receptor (INSR) gene expression via direct binding to the INSR promoter

Oncotarget ◽  
2020 ◽  
Vol 11 (25) ◽  
pp. 2424-2437
Author(s):  
Rive Sarfstein ◽  
Haim Werner
Oncogene ◽  
2006 ◽  
Vol 25 (28) ◽  
pp. 3939-3947 ◽  
Author(s):  
L Baraz ◽  
Y Haupt ◽  
M Elkin ◽  
T Peretz ◽  
I Vlodavsky

2004 ◽  
Vol 64 (7) ◽  
pp. 2627-2633 ◽  
Author(s):  
Fabiana Schwartzenberg-Bar-Yoseph ◽  
Michal Armoni ◽  
Eddy Karnieli

2009 ◽  
Vol 131 ◽  
pp. S63-S64
Author(s):  
Vikas Sood ◽  
Rajesh Ranjan ◽  
V. Ramachandran ◽  
Akhil Banerjea

2004 ◽  
Vol 24 (3) ◽  
pp. 1132-1142 ◽  
Author(s):  
Koji Nakade ◽  
Hong Zheng ◽  
Gitali Ganguli ◽  
Gilles Buchwalter ◽  
Christian Gross ◽  
...  

ABSTRACT The tumor suppressor function of p53 is linked to its ability to repress gene expression, but the mechanisms of specific gene repression are poorly understood. We report that wild-type p53 inhibits an effector of the Ras oncogene/mitogen-activated protein (MAP) kinase pathway, the transcription factor Net. Tumor-associated mutant p53s are less efficient inhibitors. p53 inhibits by preventing phosphorylation of Net by MAP kinases. Loss of p53 in vivo leads to increased Net phosphorylation in response to wound healing and UV irradiation of skin. Our results show that p53 can repress specific gene expression by inhibiting Net, a factor implicated in cell cycle entry.


2016 ◽  
Vol 52 (10) ◽  
pp. 2137-2140 ◽  
Author(s):  
Mei-Hwa Lee ◽  
James L. Thomas ◽  
Jian-Zhou Chen ◽  
Jeng-Shiung Jan ◽  
Hung-Yin Lin

Chitosan nanoparticles imprinted with thymine (and containing magnetic nanoparticles for ease in separations) were found to have dramatic effects on the expression of p53 in HepG2 cells.


FEBS Letters ◽  
2007 ◽  
Vol 581 (6) ◽  
pp. 1166-1172 ◽  
Author(s):  
Karen Rother ◽  
Markus Dengl ◽  
Jana Lorenz ◽  
Katrin Tschöp ◽  
Ralf Kirschner ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document